Subcutaneous rituximab in indolent primary cutaneous B cell lymphoma: A case series of 5 patients with the evaluation of the medico economic impact. - Fassanaro C; Mortier L; Carpentier O; Arib I; Dervaux B; Faiz S (Therapie, 2025)